{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T02:33:12Z","timestamp":1777084392025,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030117"],"award-info":[{"award-number":["82030117"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Integrative Medicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.joim.2021.10.004","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T20:44:35Z","timestamp":1635281075000},"page":"34-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey"],"prefix":"10.1016","volume":"20","author":[{"given":"Jing","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-wan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-mei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-quan","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.joim.2021.10.004_b0005","doi-asserted-by":"crossref","first-page":"138882","DOI":"10.1016\/j.scitotenv.2020.138882","article-title":"COVID-19 outbreak: migration, effects on society, global environment and prevention","volume":"728","author":"Chakraborty","year":"2020","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.joim.2021.10.004_b0010","unstructured":"World Health Organization. COVID-19 weekly epidemiological update. (2021-09-21) [2021-09-27]. https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19---21-september-2021."},{"issue":"7","key":"10.1016\/j.joim.2021.10.004_b0015","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3390\/vaccines9070696","article-title":"Predictors of intention to vaccinate against COVID-19 in the general public in Hong Kong: findings from a population-based, cross-sectional survey","volume":"9","author":"Yan","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.joim.2021.10.004_b0020","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3390\/v12040372","article-title":"Virology, epidemiology, pathogenesis, and control of COVID-19","volume":"12","author":"Jin","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.joim.2021.10.004_b0025","unstructured":"National Health Commission of the People\u2019s Republic of China. Notice on issuing the diagnosis and treatment plan for pneumonia infected by novel coronavirus (trial eighth edition). (2021-04-14) [2021-09-12]. http:\/\/www.nhc.gov.cn\/xcs\/zhengcwj\/202104\/7de0b3837c8b4606a0594aeb0105232b.shtml."},{"key":"10.1016\/j.joim.2021.10.004_b0030","unstructured":"National Health Commission of the People\u2019s Republic of China. Document of the press conference of State Council Information Office on March 23, 2020. (2020-03-23) [2021-09-12]. http:\/\/www.nhc.gov.cn\/xcs\/yqfkdt\/202003\/3ae4901e428b46ea90065f29e56cdbd1.shtml."},{"issue":"2","key":"10.1016\/j.joim.2021.10.004_b0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.joim.2020.02.004","article-title":"Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2)","volume":"18","author":"Ling","year":"2020","journal-title":"J Integr Med"},{"key":"10.1016\/j.joim.2021.10.004_b0040","doi-asserted-by":"crossref","first-page":"153671","DOI":"10.1016\/j.phymed.2021.153671","article-title":"Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): a single-center, open-label, randomized controlled trial","volume":"91","author":"Liu","year":"2021","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.joim.2021.10.004_b0045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.joim.2020.03.004","article-title":"Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: network-molecular docking-LC-MSE analysis","volume":"18","author":"Zhang","year":"2020","journal-title":"J Integr Med"},{"issue":"5","key":"10.1016\/j.joim.2021.10.004_b0050","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.joim.2020.07.008","article-title":"Research Group for Evidence-based Chinese Medicine. Chinese herbal medicine for COVID-19: current evidence with systematic review and meta-analysis","volume":"18","author":"Fan","year":"2020","journal-title":"J Integr Med"},{"issue":"1","key":"10.1016\/j.joim.2021.10.004_b0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.joim.2020.10.002","article-title":"Effects of Tanreqing Capsule on the negative conversion time of nucleic acid in patients with COVID-19: a retrospective cohort study","volume":"19","author":"Zhang","year":"2021","journal-title":"J Integr Med"},{"issue":"2","key":"10.1016\/j.joim.2021.10.004_b0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","article-title":"Viral targets for vaccines against COVID-19","volume":"21","author":"Dai","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.joim.2021.10.004_b0065","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cell.2020.06.008","article-title":"Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.joim.2021.10.004_b0070","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1473-3099(21)00127-4","article-title":"Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials","volume":"21","author":"Yang","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"27","key":"10.1016\/j.joim.2021.10.004_b0075","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"10240","key":"10.1016\/j.joim.2021.10.004_b0080","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0140-6736(20)31239-3","article-title":"The starting line for COVID-19 vaccine development","volume":"395","author":"Lee","year":"2020","journal-title":"Lancet"},{"issue":"7862","key":"10.1016\/j.joim.2021.10.004_b0085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/d41586-021-01497-8","article-title":"WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic","volume":"594","author":"Mallapaty","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.joim.2021.10.004_b0090","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.joim.2021.10.004_b0095","doi-asserted-by":"crossref","first-page":"519","DOI":"10.20892\/j.issn.2095-3941.2020.0289","article-title":"COVID-19 in cancer patients: risk, clinical features, and management","volume":"17","author":"Liu","year":"2020","journal-title":"Cancer Biol Med"},{"issue":"4","key":"10.1016\/j.joim.2021.10.004_b0100","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.annonc.2020.12.019","article-title":"Commentary: SARS-CoV-2 vaccines and cancer patients","volume":"32","author":"Corti","year":"2021","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.joim.2021.10.004_b0105","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S1470-2045(21)00250-3","article-title":"COVID-19 vaccines in patients with cancer","volume":"22","author":"Trapani","year":"2021","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.joim.2021.10.004_b0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41571-021-00487-z","article-title":"COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials","volume":"18","author":"Desai","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.joim.2021.10.004_b0115","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.annonc.2021.01.068","article-title":"The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: vaccinate","volume":"32","author":"Garassino","year":"2021","journal-title":"Monitor. Educate. Ann Oncol"},{"key":"10.1016\/j.joim.2021.10.004_b0120","unstructured":"National Comprehensive Cancer Network. Cancer and COVID-19 vaccination (version 4.0). (2021-08-30) [2021-09-12]. https:\/\/www.nccn.org\/docs\/default-source\/covid-19\/2021_covid-19_vaccination_guidance_v4-0.pdf?sfvrsn=b483da2b_70."},{"issue":"6","key":"10.1016\/j.joim.2021.10.004_b0125","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1470-2045(21)00213-8","article-title":"Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study","volume":"22","author":"Monin","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.joim.2021.10.004_b0130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13045-021-01046-w","article-title":"COVID-19 vaccines for patients with cancer: benefits likely outweigh risks","volume":"14","author":"Hwang","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.joim.2021.10.004_b0135","unstructured":"World Health Organization. Ten threats to global health in 2019. (2021) [2021-09-27]. https:\/\/www.who.int\/news-room\/spotlight\/ten-threats-to-global-health-in-2019."},{"issue":"5","key":"10.1016\/j.joim.2021.10.004_b0140","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.annonc.2021.01.066","article-title":"Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey","volume":"32","author":"Barri\u00e8re","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.joim.2021.10.004_b0145","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejca.2021.05.006","article-title":"The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: early data from a single-institute survey","volume":"153","author":"Di Noia","year":"2021","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.joim.2021.10.004_b0150","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3390\/vaccines9050411","article-title":"Attitude of patients with cancer towards vaccinations-results of online survey with special focus on the vaccination against COVID-19","volume":"9","author":"Brodziak","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"10.1016\/j.joim.2021.10.004_b0155","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/vaccines8030482","article-title":"Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China","volume":"8","author":"Wang","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"10.1016\/j.joim.2021.10.004_b0160","doi-asserted-by":"crossref","first-page":"e0248892","DOI":"10.1371\/journal.pone.0248892","article-title":"COVID-19 vaccine hesitancy and resistance: correlates in a nationally representative longitudinal survey of the Australian population","volume":"16","author":"Edwards","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.joim.2021.10.004_b0165","first-page":"100223","article-title":"Reasons for being unsure or unwilling regarding intention to take COVID-19 vaccine among Japanese people: a large cross-sectional national survey","volume":"14","author":"Nomura","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"issue":"6","key":"10.1016\/j.joim.2021.10.004_b0170","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3390\/vaccines9060633","article-title":"Factors influencing SARS-CoV-2 vaccine acceptance and hesitancy in a population-based sample in Italy","volume":"9","author":"Del Riccio","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"10.1016\/j.joim.2021.10.004_b0175","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3390\/vaccines9070704","article-title":"Real-world acceptance of COVID-19 vaccines among healthcare workers in perinatal medicine in China","volume":"9","author":"Xu","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"10.1016\/j.joim.2021.10.004_b0180","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/vaccines9050472","article-title":"Sensitivity to COVID-19 vaccine effectiveness and safety in Shanghai, China","volume":"9","author":"Lu","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.joim.2021.10.004_b0185","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1186\/s12889-021-11071-6","article-title":"A survey on COVID-19 vaccine acceptance and concern among Malaysians","volume":"21","author":"Syed Alwi","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.joim.2021.10.004_b0190","doi-asserted-by":"crossref","first-page":"110995","DOI":"10.1016\/j.paid.2021.110995","article-title":"Conspiracy beliefs and trust as determinants of COVID-19 vaccine acceptance in Bali, Indonesia: cross-sectional study","volume":"180","author":"Wirawan","year":"2021","journal-title":"Pers Individ Dif"},{"key":"10.1016\/j.joim.2021.10.004_b0195","doi-asserted-by":"crossref","first-page":"102059","DOI":"10.1016\/j.tmaid.2021.102059","article-title":"Cross-sectional analysis of COVID-19 vaccine intention, perceptions and hesitancy across Latin America and the Caribbean","volume":"41","author":"Urrunaga-Pastor","year":"2021","journal-title":"Travel Med Infect Dis"},{"issue":"5","key":"10.1016\/j.joim.2021.10.004_b0200","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3390\/vaccines9050516","article-title":"Knowledge, attitude and perceptions of COVID-19 vaccination among healthcare workers of an inner-city hospital in New York","volume":"9","author":"Ciardi","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"10.1016\/j.joim.2021.10.004_b0205","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/vaccines9050503","article-title":"Attitude toward vaccination against COVID-19 in Poland. A longitudinal study performed before and two months after the commencement of the population vaccination programme in Poland","volume":"9","author":"Babicki","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.joim.2021.10.004_b0210","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.joim.2021.10.004_b0215","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijid.2020.03.076","article-title":"Spatial epidemic dynamics of the COVID-19 outbreak in China","volume":"94","author":"Kang","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10.1016\/j.joim.2021.10.004_b0220","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/vaccines9050443","article-title":"Confidence, acceptance and willingness to pay for the COVID-19 vaccine among migrants in Shanghai, China: a cross-sectional study","volume":"9","author":"Han","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"10.1016\/j.joim.2021.10.004_b0225","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.dsx.2021.04.004","article-title":"Development and validation of a questionnaire to assess knowledge, attitude, practices, and concerns regarding COVID-19 vaccination among the general population","volume":"15","author":"Kumari","year":"2021","journal-title":"Diabetes Metab Syndr"},{"issue":"12","key":"10.1016\/j.joim.2021.10.004_b0230","doi-asserted-by":"crossref","first-page":"964","DOI":"10.7326\/M20-3569","article-title":"Attitudes toward a potential SARS-CoV-2 vaccine: a survey of U.S. adults","volume":"173","author":"Fisher","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.joim.2021.10.004_b0235","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.2147\/IDR.S312116","article-title":"Understanding of COVID-19 vaccine knowledge, attitude, acceptance, and determinants of COVID-19 vaccine acceptance among adult population in Ethiopia","volume":"14","author":"Abebe","year":"2021","journal-title":"Infect Drug Resist"},{"issue":"12","key":"10.1016\/j.joim.2021.10.004_b0240","doi-asserted-by":"crossref","first-page":"e0008961","DOI":"10.1371\/journal.pntd.0008961","article-title":"Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China","volume":"14","author":"Lin","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.joim.2021.10.004_b0245","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/vaccines9040382","article-title":"The perception and attitude toward COVID-19 vaccines: a cross-sectional study in Poland","volume":"9","author":"Rzymski","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.joim.2021.10.004_b0250","first-page":"122","article-title":"Sample size guidelines for logistic regression from observational studies with large population: emphasis on the accuracy between statistics and parameters based on real life clinical data. Malays","volume":"25","author":"Bujang","year":"2018","journal-title":"J Med Sci"},{"key":"10.1016\/j.joim.2021.10.004_b0255","doi-asserted-by":"crossref","first-page":"153337","DOI":"10.1016\/j.phymed.2020.153337","article-title":"Traditional Chinese herbal medicine at the forefront battle against COVID-19: clinical experience and scientific basis","volume":"80","author":"Lee","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.joim.2021.10.004_b0260","doi-asserted-by":"crossref","first-page":"105126","DOI":"10.1016\/j.phrs.2020.105126","article-title":"Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: a randomized controlled trial","volume":"161","author":"Xiao","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.joim.2021.10.004_b0265","doi-asserted-by":"crossref","first-page":"105056","DOI":"10.1016\/j.phrs.2020.105056","article-title":"Chinese herbal medicine for coronavirus disease 2019: a systematic review and meta-analysis","volume":"160","author":"Xiong","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.joim.2021.10.004_b0270","unstructured":"National Health Commission of People\u2019s Republic of China. Technical guideline for the inoculation of COVID-19 vaccines. (2021-03-29) [2021-09-27]. http:\/\/www.nhc.gov.cn\/jkj\/s3582\/202103\/c2febfd04fc5498f916b1be080905771.shtml."},{"issue":"1","key":"10.1016\/j.joim.2021.10.004_b0275","first-page":"289","article-title":"Understanding COVID-19 vaccine hesitancy and resistance: another challenge in cancer patients","volume":"30","author":"Mejri","year":"2021","journal-title":"Support Care Cancer"},{"issue":"31","key":"10.1016\/j.joim.2021.10.004_b0280","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.2217\/fon-2021-0265","article-title":"Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey","volume":"17","author":"Moujaess","year":"2021","journal-title":"Future Oncol"},{"issue":"15","key":"10.1016\/j.joim.2021.10.004_b0285","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.3390\/cancers13153883","article-title":"Cancer patients\u2019 willingness to take COVID-19 vaccination: a nationwide multicenter survey in Korea","volume":"13","author":"Chun","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.joim.2021.10.004_b0290","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3390\/vaccines9050411","article-title":"Attitudes of patients with cancer towards vaccinations\u2014results of online survey with special focus on the vaccination against COVID-19","volume":"9","author":"Brodziak","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.joim.2021.10.004_b0295","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1186\/s12889-021-10987-3","article-title":"Knowledge, attitude, and acceptance of healthcare workers and the public regarding the COVID-19 vaccine: a cross-sectional study","volume":"21","author":"Elhadi","year":"2021","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1016\/j.joim.2021.10.004_b0300","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines9050515","article-title":"Factors affecting COVID-19 vaccine acceptance: an international survey among low- and middle-income countries","volume":"9","author":"Bono","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"10.1016\/j.joim.2021.10.004_b0305","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting","volume":"385","author":"Barda","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joim.2021.10.004_b0310","doi-asserted-by":"crossref","unstructured":"Ligumsky H, Safadi E, Etan T, Vaknin N, Waller M, Croll A, et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine among actively treated cancer patients. J Natl Cancer Inst 2021; https:\/\/doi.org\/10.1093\/jnci\/djab174.","DOI":"10.1093\/jnci\/djab174"}],"container-title":["Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496421000996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496421000996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:52:25Z","timestamp":1761864745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095496421000996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2095496421000996"],"URL":"https:\/\/doi.org\/10.1016\/j.joim.2021.10.004","relation":{},"ISSN":["2095-4964"],"issn-type":[{"value":"2095-4964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey","name":"articletitle","label":"Article Title"},{"value":"Journal of Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joim.2021.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}